Investments
3Portfolio Exits
1
Want to inform investors similar to Sinopharm Investment about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Sinopharm Investment Investments
3 Investments
Sinopharm Investment has made 3 investments. Their latest investment was in China National Biotech Group as part of their Series A on March 3, 2022.
Sinopharm Investment Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
3/23/2022 | Series A | China National Biotech Group | Yes | 1 | ||
12/13/2021 | Series D | |||||
6/13/2020 | Corporate Minority |
Date | 3/23/2022 | 12/13/2021 | 6/13/2020 |
|---|---|---|---|
Round | Series A | Series D | Corporate Minority |
Company | China National Biotech Group | ||
Amount | |||
New? | Yes | ||
Co-Investors | |||
Sources | 1 |
Sinopharm Investment Portfolio Exits
1 Portfolio Exit
Sinopharm Investment has 1 portfolio exit. Their latest portfolio exit was MXB Biotechnologies on September 08, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
9/8/2021 | Corporate Majority - II | 1 |
Date | 9/8/2021 |
|---|---|
Exit | Corporate Majority - II |
Companies | |
Valuation | |
Acquirer | |
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.